Rhythm Pharmaceuticals, Inc. (RYTM) Balance Sheet
As of 2026-06-30 (10-Q), Rhythm Pharmaceuticals, Inc. (RYTM) reported total assets of $437.3M, total liabilities of $220.0M and shareholders' equity of $103.0M, according to EquiReason's reading of its SEC filings. Cash and equivalents: $65.6M. Long-term debt: $93.4M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
RYTMRhythm Pharmaceuticals, Inc.Follow RYTM — free
—
Price chart with a free account
- Market cap
- 6.1B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 3 Nov, in 10 days
| Line | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | Latest Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 34.2 | 49.5 | 62.3 | 100.9 | 59.2 | 127.7 | 60.1 | 89.1 | 54.3 | 65.6 | |
| Short-term investments | 113.8 | — | 230.2 | 71.9 | 235.6 | 205.6 | 215.8 | 231.4 | 334.6 | 265.3 | |
| Receivables | — | — | — | — | 1.0 | 6.2 | 14.9 | 18.5 | 26.1 | 40.4 | |
| Inventory | — | — | — | — | 0.1 | 2.9 | 8.6 | 18.7 | 25.8 | 30.5 | |
| Current assets | 150.7 | 258.7 | 302.4 | 181.7 | 308.4 | 354.2 | 308.3 | 374.2 | 466.9 | 426.6 | |
| Total assets | 151.7 | 260.2 | 308.5 | 187.1 | 329.5 | 382.5 | 332.7 | 392.3 | 480.2 | 437.3 | |
| Current liabilities | 6.7 | 13.6 | 24.4 | 18.0 | 43.4 | 39.8 | 55.2 | 115.5 | 105.9 | 123.6 | |
| Long-term debt | — | — | — | — | — | — | 106.1 | 108.3 | 100.9 | 93.4 | |
| Short-term debt | — | — | — | — | — | — | — | 1.5 | 7.3 | 12.7 | |
| Total liabilities | 6.9 | 14.0 | 27.5 | 20.5 | 45.4 | 118.2 | 163.0 | 227.7 | 210.2 | 220.0 | |
| Shareholders' equity | 144.8 | 246.3 | 281.0 | 166.5 | 284.2 | 264.3 | 169.8 | 21.7 | 139.1 | 103.0 |
USD millions · SEC XBRL
Rhythm Pharmaceuticals, Inc. — questions
- How much cash does Rhythm Pharmaceuticals, Inc. have?
- $65.6M in cash and cash equivalents as of 2026-06-30.
- How much debt does Rhythm Pharmaceuticals, Inc. have?
- $93.4M of long-term debt and $12.7M due within a year as of 2026-06-30.
- What are Rhythm Pharmaceuticals, Inc.'s total assets?
- $437.3M as of 2026-06-30.
- What is Rhythm Pharmaceuticals, Inc.'s shareholders' equity?
- $103.0M as of 2026-06-30.
Every figure on this page comes from Rhythm Pharmaceuticals, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.